IDIBAPS at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
IDIBAPS brings 8 presentations to ESGCT 2026 in Hamburg. Its work centres on CAR T cell engineering for blood cancers and solid tumours, including switches that release armoured payloads only when the cells are active. A second strand develops oncolytic adenoviruses carrying immune-activating genes.
| Organization | ESGCT 2026 Attendance |
|---|---|
IDIBAPS Barcelona, Spain | |
Biomedical research institute of Hospital Clínic de Barcelona, which developed an academic CD19 CAR-T therapy. | Chair Wed Oct 28 11:00am–12:30pm SESSION 4c: Immunotherapy and CAR T cells II Cell therapies and CAR-T Poster Wed Oct 28 1:30pm–3:30pm ImmTAC-Secreting T Cells Mediate Potent Antitumor Activity in Melanoma Poster Wed Oct 28 1:30pm–3:30pm Oncolytic adenovirus expressing soluble LIF receptor (ICOVIR15kd-sLIFR) enhances antitumor immune responses in preclinical models of pancreatic cancer Poster Wed Oct 28 1:30pm–3:30pm Oncolytic adenoviruses armed with PDT (AdNuPAR-PDT) activate nucleoside prodrugs to induce bystander killing and trigger effective anticancer effects Poster Wed Oct 28 1:30pm–3:30pm Targeting the PD-1/PD-L1 Axis Through Intrabody-Mediated Retention to Improve CAR T-Cell Efficacy Poster Thu Oct 29 2:00pm–4:00pm Generation of a Nonviral CRISPR/Cas9-Engineered CAR-T Cell Therapy for Glioblastoma Poster Thu Oct 29 2:00pm–4:00pm Preclinical characterization of CD7negative T cells as a platform for anti-CD7 CAR-T cell therapy in T-cell malignancies Poster Thu Oct 29 2:00pm–4:00pm Tonic signaling in 4-1BB HER2 CAR-T cells is context-dependent and shaped by manufacturing conditions Talk Thu Oct 29 5:45pm–6:00pm |
Instantly find 20 buyers from IDIBAPS
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction